International private equity firm Cinven today announces that it has appointed Philipp Meyer as Partner with effect from 3rd February 2025.
Philipp will join Cinven from The Carlyle Group, where he was a Managing Director in the European Buyout fund and Co-Head of Healthcare in Europe. In his 18 years at Carlyle, based in Munich, he was responsible for investment origination, execution, portfolio management and realisations in the healthcare sector across Europe. Philipp played an active role in investments including the $3.8bn acquisition of Vantive, Baxter’s global kidney care segment, the £1.2bn acquisition of Theramex, a leading European women’s health pharma company, and others including: MAK-System, Schön Klinik, Alloheim, Axalta Coating Systems, AZ Electronic Materials, H.C. Starck and Edscha.
Prior to joining Carlyle, Philipp worked at UBS Investment Bank and McKinsey & Company.
At Cinven, Philipp will focus on the DACH region and the European Healthcare sector, drawing on his significant experience in the sector. He will be based in Frankfurt.
Cinven is a leading investor in the DACH region, with a long and successful track record. Cinven has made a number of attractive investments across the DACH region in recent years, including co-leading the acquisitions of TK Elevator from ThyssenKrupp AG in February 2020 and Arxada (previously Lonza Specialty Ingredients) from Lonza Group AG in February 2021, and most recently agreeing a new strategic investment in Fressnapf Group, a leading European pet supplies business. Cinven’s German-headquartered portfolio includes Master Builders Solutions, a leading global manufacturer of concrete admixtures, think-cell, a leading productivity software provider that creates data-driven presentations in Microsoft PowerPoint and Viridium, a consolidation platform for the German life insurance market.
Cinven also has a strong track record in the healthcare sector with DACH investments including STADA, a leading manufacturer of over-the-counter, generics and specialty pharmaceuticals and SYNLAB, the largest European clinical laboratory and medical diagnostic services company. Investments outside of DACH in the healthcare sector include: Clario (formed from the combination of Bioclinica and ERT), a leading data and technology provider for clinical trials, LGC, a leading global life science tools company active in the standards and genomic spaces, Medpace, a global CRO and National Seating & Mobility (NSM), a provider of custom-made accessibility solutions. Cinven also invested in Envirotainer, a global provider of cold chain logistics to pharmaceutical and biotech clients.
Commenting on Philipp’s appointment, Bruno Schick, Co-Managing Partner and Head of the DACH team at Cinven said:
“We are thrilled to welcome Philipp as a Partner at Cinven. His appointment reflects our ongoing commitment to investing in the growth of our business, seizing new opportunities and continuing to build on our market leading momentum. Beyond his experience, Philipp shares Cinven’s values of partnership and commitment to excellence. Cinven has strong and proven track records in both the healthcare sector and DACH region. His collaboration will further enhance our ability to drive innovation and deliver exceptional results.”
Pontus Pettersson, Partner and Head of the Healthcare sector team at Cinven, commented:
“Splitting his time between our DACH and healthcare sector teams, Philipp brings a unique perspective and deep industry knowledge that will undoubtedly strengthen our capabilities and continue to drive success for Cinven and our investors. Alongside his extensive industry experience, Philipp is a proven leader, bringing with him an impressive network in the healthcare space. He will be instrumental in identifying new strategic investment opportunities and collaborating closely with our portfolio companies. We are excited to welcome him to the team.”
Philipp Meyer, Partner at Cinven, added:
“I am delighted to join Cinven, a firm with an outstanding reputation and a strong track record of creating value and driving impact across its portfolio companies. Joining Cinven is an exciting opportunity to work alongside a talented team, leverage my experience, and help drive growth in both the healthcare sector and DACH region; two dynamic areas. I look forward to partnering with the Cinven team and management teams to create meaningful and sustained value.”
